CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the ...

The challenges of diabetes are real and we live with them every single day. It’s 1:30 am and I’m sitting in Leah’s room. I ...

Modular Medical (Nasdaq:MODD) announced recently that it priced an underwritten public offering worth proceeds of around $8.2 ...

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

On Tuesday, Embecta Corp (NASDAQ:EMBC) posted the fourth-quarter adjusted EPS of 45 cents, beating the consensus of 36 cents ...

Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our ...

Sequel Med Tech is working to sell a new, more precise type of insulin pump that can measure the amount of insulin delivered to users. CEO Alan Lotvin, former president of pharmacy benefit manager CVS ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Florida mom Kelsey Glover, who was arrested after her 14-year-old daughter was found dead in a bathtub, has been charged with ...

A recent study has revealed a strong link between insulin resistance and an increased risk of aortic stenosis (AS), a ...